Beverage consumption and paediatric NAFLD

Eating and Weight Disorders

Volumn 21, Issue 4, 2016, Pages 581-588

  Mosca, Antonella ^b   Della Corte, Claudia ^a   Sartorelli, Maria Rita ^a   Ferretti, Francesca ^a   Nicita, Francesco ^b   Vania, Andrea ^b   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adolescents; Alcohol; Energy drinks; Fructose; NAFLD; Soft drinks

Indexed keywords

ALCOHOL; ASPARTAME; FRUCTOSE; NICOTINIC ACID; TAURINE; XANTHINE;

ALCOHOL CONSUMPTION; BEVERAGE; CHILDHOOD DISEASE; DIET; DISEASE COURSE; ENERGY DRINK; FOOD INTAKE; HUMAN; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; REVIEW; SOFT DRINK; SUGAR INTAKE; ADOLESCENT; ADVERSE EFFECTS; CARBONATED BEVERAGE; CHILD; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

ADOLESCENT; CARBONATED BEVERAGES; CHILD; DIET; ENERGY DRINKS; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84995685163     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: 10.1007/s40519-016-0315-3     Document Type: Review

References (52)

1. Malik VS, Popkin BM, Bray GA, Despres J-P, Hu FB (2010) Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 121:1356–1364. doi:10.1161/CIRCULATIONAHA.109.876185
2. Zimmermann MB, Gübeli C, Püntener C, Molinari L (2004) Detection of overweight and obesity in a national sample of 6–12-y-old Swiss children: accuracy and validity of reference values for body mass index from the US Centers for Disease Control and Prevention and the International Obesity Task Force. Am J Clin Nutr 79:838–843
3. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S (2009) The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 58:1538–1544. doi:10.1136/gut.2008.171280
4. Vos MB, Lavine JE (2013) Dietary fructose in nonalcoholic fatty liver disease. Hepatology 57:2525–2531. doi:10.1002/hep.26299
5. Atabek ME, Selver Eklioglu B, Akyurek N (2014) Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children? Eat Weight Disord 19(4):495–501. doi:10.1007/s40519-014-0129-0
6. Nielsen SJ, Popkin BM (2004) Changes in beverage intake between 1977 and 2001. Am J Prev Med 27:205–210
7. European Food Safety Authority (2010) Scientific opinion on dietary reference values for carbohydrates and dietary fibre. EFSA J 8(3):1462. doi:10.2903/j.efsa.2010.1462
8. Flotta D, Micò R, Nobile CG, Pileggi C, Bianco A, Pavia M (2014) Consumption of energy drinks, alcohol, and alcohol-mixed energy drinks among Italian adolescents. Alcohol Clin Exp Res 38(6):1654–1661. doi:10.1111/acer.12394
9. Peirson L, Fitzpatrick-Lewis D, Morrison K, Ciliska D, Kenny M, Usman Ali M, Raina P (2015) Prevention of overweight and obesity in children and youth: a systematic review and meta-analysis. CMAJ Open 3(1):E23–E33. doi:10.9778/cmajo.20140053
10. Skinner AC, Skelton JA (2014) Prevalence and trends in obesity and severe obesity among children in the United States, 1999–2012. JAMA Pediatr 168:561–566. doi:10.1001/jamapediatrics.2014.21
11. Day CP, James OF (1998) Steatohepatitis: a tale of two “hits”? Gastroenterology 114:842–845. doi:10.1016/S0016-5085(98)70599-2
12. Nobili V, Svegliati-Baroni G, Alisi A (2013) A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol 58:1218–1229. doi:10.1016/j.jhep.2012.12.003
13. Vitturi N, Soattin M, De Stefano F, Vianello D, Zambon A, Plebani M, Busetto L (2015) Ultrasound, anthropometry and bioimpedance: a comparison in predicting fat deposition in non-alcoholic fatty liver disease. Eat Weight Disord 20(2):241–247. doi:10.1007/s40519-014-0146-z
14. Kawada T (2016) Prediction of non-alcoholic fatty liver disease by obesity indices. Eat Weight Disord 21(2):313–314. doi:10.1007/s40519-015-0224-x
15. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R (2007) Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 47:711–717. doi:10.1016/j.jhep.2007.06.020
16. Bray GA, Popkin BM (2013) Calorie-sweetened beverages and fructose: what have we learned 10 years later. Pediatr Obes 8(4):242–248. doi:10.1111/j.2047-6310.2013.00171.x
17. WHO (2014) Guideline: sugars intake for adults and children: draft guidelines on free sugars released for public consultation. WHO, Geneva
18. Scientific Advisory Committee on Nutrition (2014) Draft carbohydrates and health report. The Stationary Office, London
19. WHO Health Organization (2015) Sugars intake adults and children. Guideline. ISBN: 978 92 4154902 8. http://www.who.int/mediacentre/news/releases/2015/sugar-guideline/en/.
20. Chaloupka FJ, Powell LM, Chriqui JF (2009) Sugar-Sweetened Beverage Taxes and Public Health. http://www.rwjf.org/files/research/20090715beveragetaxresearchbrief.pdf
21. US Beverage Information Group (2013) US beverage alcohol trends. http://www.usdrinksconference.com/assets/files/agenda/US%20Beverage%20Alcohol%20Trends.pdf
22. William N, Fares N, Nimer A (2010) Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol 16(21):2579–2588. doi:10.3748/wjg.v16.i21.2579
23. Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D’Agostino RB, Gaziano JM, Vasan R (2007) Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 116(5):480–488. doi:10.1161/CIRCULATIONAHA.107.689935
24. Moeller SM, Fryhofer SA, Osbahr AJ (2009) The effects of high fructose syrup. J Am Coll Nutr 28:619–626
25. Basaranoglu M, Basaranoglu G, Bugianesi E (2015) Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepat Surg Nutr 4(2):109–116. doi:10.3978/j.issn.2304-3881.2014.11.05
26. Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I (2009) Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50:1094–1104. doi:10.1002/hep.23122
27. Lê KA, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P, Boesch C, Ravussin E, Tappy L (2006) A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr 84:1374–1379. doi:10.3945/ajcn.2008.27336
28. Lê KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L (2009) Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 89:1760–1765. doi:10.3945/ajcn.2008.27336
29. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF (2008) Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48:993–999. doi:10.1016/j.jhep.2008.02.011
30. Petrie JL, Patman GL, Sinha I, Alexander TD, Reeves HL, Agius L (2013) The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis. Am J Physiol Endocrinol Metab 305(10):E1255–E1265. doi:10.1152/ajpendo.00214.2013
31. Moore JB, Gunn PJ, Fielding BA (2014) The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease. Nutrients 6(12):5679–5703. doi:10.3390/nu6125679
32. Adaramoye OA, Akanni OO (2016) Effects of long-term administration of aspartame on biochemical indices, lipid profile and redox status of cellular system of male rats. J Basic Clin Physiol Pharmacol 27(1):29–37. doi:10.1515/jbcpp-2014-0130
33. Soft Drink & Ice Canada and USA Report (2016). http://www.researchandmarkets.com/reports/3519562/soft-drink-and-ice-canada-and-usa-report
34. Zucconi S, Volpato C, Adinolfi F, Gandini E,Gentile E, Loi A, Fioriti L (2013) Gathering consumption data on specific consumer groups of energy drinks. 10(3). http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/394e.pdf
35. Saab S, Mallam D, Cox GA, Tong MJ (2014) Impact of coffee on liver diseases: a systematic review. Liver Int 34(4):495–504. doi:10.1111/liv.12304
36. Catalano D, Martines GF, Tonzuso A, Pirri C, Trovato FM, Trovato GM (2010) Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 55:3200–3206. doi:10.1007/s10620-010-1143-3
37. Molloy JW, Calcagno CJ, Williams CD, Jones FJ, Torres DM, Harrison SA (2012) Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 55(2):429–436. doi:10.1002/hep.24731
38. Dranoff JA, Feld JJ, Lavoie EG (2014) Fausther M. How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations. Hepatology 60(2):464–467. doi:10.1002/hep.27032
39. Huang B, Kunkel D, El Kabany M (2014) Acute liver failure following one year of daily consumption of a sugar-free energy drink. ACG Case Rep J 1(4):214–216. doi:10.14309/crj.2014.57
40. Hu M, Chu WCW, Yamashita S, Yeung DKW, Shi L, Wang D, Masuda D, Yang Y, Tomlinson B (2012) Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients. J Lipid Res 53(4):802–809. doi:10.1194/jlr.P023614
41. Ferreira SE, de Mello MT, Pompéia S, de Souza-Formigoni ML (2006) Effects of energy drink ingestion on alcohol intoxication. Alcohol Clin Exp Res 30(4):598–605. doi:10.1111/j.1530-0277.2006.00070.x
42. European Monitoring Centre for Drugs and Drug Addiction: Summary 2011 ESPAD Report (2012) Substance use Among Students in 36 European Countries. Publications Office of the European Union, Luxembourg. http://www.can.se/contentassets/8d8cb78bbd28493b9030c65c598e3301/the_2011_espad_report_full.pdf
43. European Monitoring Centre for Drugs and Drug Addiction: Summary 2011 ESPAD Report (2012) Substance use among students in 36 European countries. Publications Office of the European Union, Luxembourg
44. Nobili V, Pinzani M (2001) Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence. Alcohol Alcohol 46:627–629. doi:10.1093/alcalc/agr074
45. Naimi TS, Brewer RD, Mokdad A (2013) Binge drinking among US adults. JAMA 289:70–75. doi:10.1001/jama.289.1.70
46. Morita Y, Ueno T, Sasaki N, Kuhara K, Yoshioka S, Tateishi Y, Nagata E, Kage M, Sata M (2005) Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan. Alcohol Clin Exp Res 277S–281S. doi: 10.1097/01.alc.0000191777.36629.33
47. Xu J, Lai K, Verlinsky A, Lugea A, French SW, Cooper MP, Ji C, Tsukamoto H (2011) Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol 55:673–682. doi:10.1016/j.jhep.2010.12.034
48. Galli A, Price D, Crabb D (1999) High-level expression of rat class I alcohol dehydrogenases is sufficient for ethanol-induced fat accumulation in transduced HeLa cells. Hepatology 29:1164–1170. doi:10.1002/hep.510290420
49. Sachse B, Meinl W, Glatt H, Monien BH (2016) Ethanol and 4-methylpyrazole increase DNA adduct formation of furfuryl alcohol in FVB/N wild-type mice and in mice expressing human sulfotransferases 1A1/1A2. Carcinogenesis. 37(3):314–319. doi:10.1093/carcin/bgw006
50. Grucza RA, Krueger RF, Racette SB, Norberg KE, Hipp PR, Bierut LJ (2010) The emerging link between alcoholism risk and obesity in the United States. Arch Gen Psychiatry 67(12):1301–1308. doi:10.1002/hep.510290420
51. Frasinariu OE, Ceccarelli S, Alisi A (2013) Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Dig Liver Dis 45(7):543–551. doi:10.1016/j.dld.2012.11.010
52. Koot BG, van der Baan-Slootweg OH, Vinke S, Bohte AE, Tamminga-Smeulders CL, Jansen PL, Stoker J, Benninga MA (2016) Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment. Int J Obes (Lond) 40(1):51–57. doi:10.1038/ijo.2015.175